These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22651792)

  • 1. Grading breast cancer on microarray samples: comparison with Nottingham grade, and use of boosting classification.
    Dalton L; Page DL
    Histopathology; 2012 Sep; 61(3):497-508. PubMed ID: 22651792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of different subtypes of breast cancer using tissue microarray.
    Munirah MA; Siti-Aishah MA; Reena MZ; Sharifah NA; Rohaizak M; Norlia A; Rafie MK; Asmiati A; Hisham A; Fuad I; Shahrun NS; Das S
    Rom J Morphol Embryol; 2011; 52(2):669-77. PubMed ID: 21655659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement.
    Dalton LW; Pinder SE; Elston CE; Ellis IO; Page DL; Dupont WD; Blamey RW
    Mod Pathol; 2000 Jul; 13(7):730-5. PubMed ID: 10912931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single pathological grading system for breast carcinoma should be adopted in Sri Lanka.
    de Silva MV; Tilakaratna AD; Rodrigo T
    Ceylon Med J; 1998 Dec; 43(4):232-4. PubMed ID: 10355178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification and grading of invasive breast carcinoma.
    Elston CW
    Verh Dtsch Ges Pathol; 2005; 89():35-44. PubMed ID: 18035670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization.
    Graham AD; Faratian D; Rae F; Thomas JS
    Histopathology; 2008 Jun; 52(7):847-55. PubMed ID: 18494613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there 'progression through grade' in ductal invasive breast cancer?
    Schymik B; Buerger H; Krämer A; Voss U; van der Groep P; Meinerz W; van Diest PJ; Korsching E
    Breast Cancer Res Treat; 2012 Oct; 135(3):693-703. PubMed ID: 22886478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parafibromin expression in breast cancer: a novel marker for prognostication?
    Selvarajan S; Sii LH; Lee A; Yip G; Bay BH; Tan MH; Teh BT; Tan PH
    J Clin Pathol; 2008 Jan; 61(1):64-7. PubMed ID: 17468290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of mitosis counting by automated phosphohistone H3 (PHH3) digital image analysis in a breast carcinoma tissue microarray.
    Dessauvagie BF; Thomas C; Robinson C; Frost FA; Harvey J; Sterrett GF
    Pathology; 2015 Jun; 47(4):329-34. PubMed ID: 25938351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patients.
    Nguyen B; Cusumano PG; Deck K; Kerlin D; Garcia AA; Barone JL; Rivera E; Yao K; de Snoo FA; van den Akker J; Stork-Sloots L; Generali D
    Ann Surg Oncol; 2012 Oct; 19(10):3257-63. PubMed ID: 22965266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of prognostic value of topoisomerase II alpha in patients with breast cancer: analysis with tissue microarray.
    Sheen-Chen SM; Huang CY; Zhang H; Huang CC; Tang RP
    Anticancer Res; 2010 Jun; 30(6):2459-62. PubMed ID: 20651408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of TMA and digitalization in routine diagnostics of breast pathology.
    Rossing HH; Talman ML; Laenkholm AV; Wielenga VT
    APMIS; 2012 Apr; 120(4):341-7. PubMed ID: 22429216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
    Sinha PS; Bendall S; Bates T
    Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. a single institution survey spanning 1998 to 2010.
    García Fernández A; Giménez N; Fraile M; González S; Chabrera C; Torras M; González C; Salas A; Barco I; Cirera L; Cambra MJ; Veloso E; Pessarrodona A
    Breast; 2012 Jun; 21(3):366-73. PubMed ID: 22487206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis.
    Dieci MV; Barbieri E; Bettelli S; Piacentini F; Omarini C; Ficarra G; Balduzzi S; Dominici M; Conte P; Guarneri V
    J Clin Pathol; 2012 Jun; 65(6):503-6. PubMed ID: 22389512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.
    Grönberg M; Fjällskog ML; Jirström K; Janson ET
    Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study.
    Fèvre-Montange M; Vasiljevic A; Frappaz D; Champier J; Szathmari A; Aubriot Lorton MH; Chapon F; Coulon A; Quintin Roué I; Delisle MB; Figarella-Branger D; Laquerrière A; Miquel C; Michiels JF; Péoch M; Polivka M; Fauchon F; Jouvet A
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):87-94. PubMed ID: 21696422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of breast cancer using genetic algorithms and tissue microarrays.
    Dolled-Filhart M; Rydén L; Cregger M; Jirström K; Harigopal M; Camp RL; Rimm DL
    Clin Cancer Res; 2006 Nov; 12(21):6459-68. PubMed ID: 17085660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.